STERIS plc (NYSE: STE) saw its stock soar 5.05% in after-hours trading on Wednesday, following the release of its impressive fiscal 2025 fourth-quarter earnings report and optimistic guidance for fiscal 2026. The medical equipment company's financial results surpassed analyst expectations, demonstrating robust growth across key metrics.
For the fourth quarter, STERIS reported adjusted earnings per share of $2.74, significantly beating the FactSet consensus estimate of $2.60. This represents a 13.69% increase from $2.41 per share in the same period last year. Quarterly revenue came in at $1.48 billion, slightly above the analyst consensus of $1.47 billion and marking a 4.37% year-over-year growth. The company's adjusted net income for Q4 reached $270.3 million, outperforming the IBES estimate of $257.6 million.
Looking ahead, STERIS provided an upbeat outlook for fiscal 2026, projecting adjusted EPS from continuing operations in the range of $9.90 to $10.15. The company also anticipates organic growth of 6-7% and free cash flow of approximately $770 million for the upcoming fiscal year. These positive forecasts, coupled with the strong Q4 performance, likely contributed to the significant after-hours stock price increase as investors showed confidence in STERIS's future prospects.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.